DFCM
VERV

Dark Forest Capital Management’s Verve Therapeutics VERV Stock Holding History

Dark Forest Capital Management’s Portfolio VERV Stock Details VERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-12,648
Closed -$142K – 1504
2025
Q2 		$142K Sell
12,648
-68,477
-84% -$390K 0.01% 1106
2025
Q1 		$371K Buy
81,125
+59,709
+279% +$400K 0.02% 1013
2024
Q4 		$121K Sell
21,416
-6,744
-24% -$38K 0.02% 847
2024
Q3 		$136K Sell
28,160
-19,201
-41% -$112K 0.02% 908
2024
Q2 		$231K Buy
47,361
+35,562
+301% +$224K 0.04% 527
2024
Q1 		$157K Buy
+11,799
New +$156K 0.03% 645
2022
Q4 		– Sell
-52
Closed -$2K – 1502
2022
Q3 		$2K Sell
52
-324
-86% -$10.3K ﹤0.01% 1027
2022
Q2 		$6K Sell
376
-3,065
-89% -$47.5K ﹤0.01% 620
2022
Q1 		$78K Sell
3,441
-11,096
-76% -$317K 0.02% 534
2021
Q4 		$536K Buy
+14,537
New +$611K 0.2% 118

Other funds holding VERV

GCM
Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
BIG
Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Dark Forest Capital Management's VERV Position: Q3 2025 in Review

Dark Forest Capital Management sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 12,648 shares — an estimated $142K sold.

Dark Forest Capital Management first reported a position in VERV in Q4 2021 and held it in 10 quarters. The position peaked at $536K in Q4 2021. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

  • Dark Forest Capital Management reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Dark Forest Capital Management sold 12,648 Verve Therapeutics shares in Q3 2025, an estimated $142K.
  • Dark Forest Capital Management first reported a position in Verve Therapeutics in Q4 2021 and held it in 10 quarters.
  • Dark Forest Capital Management's Verve Therapeutics position peaked at $536K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on Dark Forest Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.